EDAP TMS S.A. (FOCL)
NASDAQ: FOCL · Real-Time Price · USD
4.470
-0.290 (-6.09%)
Aug 17, 2026, 12:12 PM EDT - Market open
EDAP TMS Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 79.31 | 70.53 | 69.4 | 66.79 | 58.9 | 50.11 |
Revenue Growth | 7.17% | 1.63% | 3.90% | 13.40% | 17.52% | -1.66% |
Gross Profit Gross Profit Growth | 35.28 | 30 | 28.74 | 26.98 | 25.86 | 20.95 |
Operating Income Operating Income Growth | -27.39 | -24.7 | -22.23 | -18.14 | -4.55 | -1.83 |
Net Income Net Income Growth | -38.97 | -29.25 | -20.58 | -23.41 | -3.13 | 0.8 |
Earnings Per Share EPS Growth | -1.04 | -0.78 | -0.55 | -0.63 | -0.10 | 0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
High Intensity Focused Ultrasound (HIFU) High Intensity Focused Ultrasound (HIFU) Growth | 37.35 | 25.8 | 22.77 | 16.71 | 11.28 |
Lithotripsy (ESWL) Lithotripsy (ESWL) Growth | 7.46 | 9.72 | 10.95 | 12.36 | 12.53 |
Distribution Business Distribution Business Growth | 25.71 | 33.87 | 33.07 | 29.82 | 26.31 |
Total Total Growth | 70.53 | 69.4 | 66.79 | 58.9 | 50.11 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 21.54 | 20.45 | 31 | 48.05 | 67.47 | 53.66 |
Total Debt Total Debt Growth | 39.89 | 27.75 | 14.52 | 9.38 | 10.03 | 11.38 |
Net Cash (Debt) Net Cash Growth | -18.35 | -7.29 | 16.48 | 38.67 | 57.44 | 42.28 |
Net Cash Growth | - | - | -57.39% | -32.68% | 35.86% | 154.47% |
Net Cash Per Share Net Cash Per Share Growth | -0.49 | -0.19 | 0.44 | 1.05 | 1.67 | 1.30 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -13.03 | -16.41 | -14.7 | -16.22 | -3.23 | 5.06 |
Capital Expenditures CapEx Growth | -4.03 | -4.93 | -4.19 | -4.16 | -2.33 | -1.77 |
Free Cash Flow Free Cash Flow Growth | -17.05 | -21.34 | -18.89 | -20.38 | -5.56 | 3.29 |
Free Cash Flow Growth | - | - | - | - | - | 2411.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.48% | 42.54% | 41.42% | 40.40% | 43.90% | 41.81% |
Operating Margin | -34.53% | -35.02% | -32.03% | -27.16% | -7.72% | -3.66% |
Pretax Margin | -48.77% | -40.85% | -29.21% | -33.98% | -3.80% | 2.03% |
Profit Margin | -49.13% | -41.47% | -29.66% | -35.05% | -5.32% | 1.59% |
FCF Margin | -21.50% | -30.25% | -27.22% | -30.52% | -9.45% | 6.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 250.91 |
Forward PE | - | 207.94 | 207.94 | 207.94 | 207.94 | 207.94 |
P/FCF Ratio | - | - | - | - | - | 60.75 |
PS Ratio | 2.76 | 1.74 | 1.18 | 2.92 | 6.06 | 3.99 |